Literature DB >> 15537375

Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva.

A Garrido1, M J Martínez, J A Ortega, A Lobato, M J Rodríguez, F J Guerrero.   

Abstract

OBJECTIVE: To know the different epidemiologic aspects of chronic inflammatory bowel disease (IBD) in the Northern area of the province of Huelva.
MATERIAL AND METHODS: we carried out a retrospective (1980-1996) and prospective (1996-2003) study of all patients diagnosed with IBD in the Northern area of Huelva, with 77,856 inhabitants. The distribution of Crohn s disease (CD) and ulcerative colitis (UC) was analyzed, as well as sex, age and smoking habit at the time of diagnosis, familial aggregation, appendicectomy rate, phenotype (anatomical site and clinical types), extraintestinal manifestations, and immunosuppressive therapy or surgical requirements.
RESULTS: 70 patients with IBD were studied, 40 with UC and 30 with CD. Sex distribution was 39 (55.7%) males (55% with CD vs 56.6% with UC; NS) and 31 (44.3%) females (45% with CD vs 43.3% with UC; NS). Mean age at presentation was 44.7 +/- 19.32 years in UC vs 32.3 +/- 16.43 in CD; p < 0.001. Familial association was 7.1%. Previous appendicectomy was referred in 2.5% of patients with UC vs 36.7% of those with CD (p < 0.001), and the percentage of smokers was also higher in CD 66.7% vs CU 12.5% (p < 0.001). Anatomical site in UC was: proctitis, 20%; proctosigmoiditis/left colon, 42.5%; extensive colitis, 25%; and pancolitis, 12.5%; in CD was: terminal ileum, 43.3%; colon, 20%; and ileo-colon, 36.7%. The disease patterns were: inflammatory 56.7%, obstruction 26.7%, and fistulization 16.7%. Extraintestinal manifestations were diagnosed in 7.5% of patients with UC vs 16.6% patients with CD; surgery was performed in one patient with UC vs 10 with CD, and one patient with UC required immunosuppressive treatment vs 12 with CD. A multivariant analysis showed that younger age and smoking habit were risk factors for CD vs advanced age in UC, in which case, the smoking habit was a protective factor. The mean incidence rate of IBD starting from 1996 and expressed in cases/100,000 inhabitants/year was 5.2 for UC and 6.6 for CD.
CONCLUSIONS: The mean incidence of UC in our area was 5.2 cases/100,000/inhabitants/year, and 6.6 for CD. Patients presenting with CD are diagnosed at a significantly younger age that those with UC; the smoking habit is a risk factor for CD while it protects from UC. The characteristics of IBD in our geographical area do not differ substantially from those in other regions of Spain.

Entities:  

Mesh:

Year:  2004        PMID: 15537375     DOI: 10.4321/s1130-01082004001000003

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  9 in total

1.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

2.  IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study.

Authors:  Alexis Ramos; Xavier Calvet; Beatriz Sicilia; Mercedes Vergara; Ariadna Figuerola; Jaume Motos; Adoración Sastre; Albert Villoria; Fernando Gomollón
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

Review 3.  Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?

Authors:  Cristina Saro Gismera; Beatriz Sicilia Aladrén
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

4.  Association of the interleukin 15 (IL-15) gene polymorphisms with the risk of developing ulcerative colitis in Mexican individuals.

Authors:  Jesus K Yamamoto-Furusho; Jorge L De-León-Rendón; Edith Alvarez-León; Mario Valdivia-Eziquio; Claudia Obil-Chavarría; Gilberto Vargas-Alarcón
Journal:  Mol Biol Rep       Date:  2014-01-11       Impact factor: 2.316

Review 5.  Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?

Authors:  Ayesha Shah; Nicholas J Talley; Marjorie Walker; Natasha Koloski; Mark Morrison; Daniel Burger; Jane M Andrews; Michael McGuckin; Mike Jones; Gerald Holtmann
Journal:  Dig Dis Sci       Date:  2017-03-09       Impact factor: 3.199

6.  Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry.

Authors:  Esther A Torres; Abdiel Cruz; Mariola Monagas; Marina Bernal; Yadira Correa; Rafael Cordero; Víctor L Carlo
Journal:  Int J Inflam       Date:  2011-12-11

7.  Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).

Authors:  Ignacio Marín-Jiménez; Cristina Saro; Verónica Díaz; Manuel Barreiro-de Acosta; María Gómez-García; Ana Gutiérrez Casbas
Journal:  Drugs Context       Date:  2018-03-06

8.  EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.

Authors:  María Chaparro; Manuel Barreiro-de Acosta; José Manuel Benítez; José Luis Cabriada; María José Casanova; Daniel Ceballos; María Esteve; Hipólito Fernández; Daniel Ginard; Fernando Gomollón; Rufo Lorente; Pilar Nos; Sabino Riestra; Montserrat Rivero; Pilar Robledo; Cristina Rodríguez; Beatriz Sicilia; Emilio Torrella; Ana Garre; Esther García-Esquinas; Fernando Rodríguez-Artalejo; Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2019-05-21       Impact factor: 4.409

9.  Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts.

Authors:  Tom Thomas; Joht Singh Chandan; Venice Sze Wai Li; Cheuk Yin Lai; Whitney Tang; Neeraj Bhala; Gilaad G Kaplan; Siew C Ng; Subrata Ghosh
Journal:  PLoS One       Date:  2019-09-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.